Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138189 · ClinicalTrials.gov registry record
Wavefront-guided Versus Wavefront-optimized LASIK for Nearsightedness
A clinical trial, sponsored by Edward E. Manche.
- Completed
- Registry status
- 36
- Enrollment target
NCT01138189: Completed study, sponsored by Edward E. Manche.
NCT01138189 is a clinical trial that has completed, run by Edward E. Manche. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01138189 has completed, sponsored by Edward E. Manche.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the results of LASIK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism
Interventions
- PROCEDURE Wavefront-guided LASIK
- PROCEDURE Wavefront-optimized LASIK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-04-06 |
| Est. Completion | 2012-04-30 |
What the finished NCT01138189 record still lists
NCT01138189 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Wavefront-guided LASIK is the first listed.
NCT01138189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01138189 about?
NCT01138189 is a clinical study titled "Wavefront-guided Versus Wavefront-optimized LASIK for Nearsightedness". The purpose of the study is to compare the results of LASIK surgery when using wavefront-guided excimer laser treatment compared to wavefront optimized excimer laser treatment in patients with nearsightedness with and without astigmatism
What is the current status of trial NCT01138189?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2010-04-06. Estimated completion is 2012-04-30.
What interventions are being tested in trial NCT01138189?
The interventions under investigation include: Wavefront-guided LASIK (PROCEDURE), Wavefront-optimized LASIK (PROCEDURE).
Who is sponsoring clinical trial NCT01138189?
This trial is sponsored by Edward E. Manche, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI